PMRX_LIMITED - Accounts


Company Registration No. 09905685 (England and Wales)
PMRX LIMITED
ANNUAL REPORT
AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2019
PAGES FOR FILING WITH REGISTRAR
PMRX LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 5
PMRX LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 JULY 2019
31 July 2019
- 1 -
2019
2018
Notes
£
£
£
£
Non-current assets
Investments
3
639,562
639,562
Current assets
Cash and cash equivalents
237
164
Current liabilities
5
(29,000)
(26,250)
Net current liabilities
(28,763)
(26,086)
Total assets less current liabilities
610,799
613,476
Non-current liabilities
6
(524,574)
(556,307)
Net assets
86,225
57,169
Equity
Called up share capital
100
100
Retained earnings
86,125
57,069
Total equity
86,225
57,169

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 July 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 June 2020 and are signed on its behalf by:
Mr J Fearns
Director
Company Registration No. 09905685
PMRX LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2019
- 2 -
1
Accounting policies
Company information

PMRX Limited is a private company limited by shares incorporated in England and Wales. The registered office is Carlyle House, 78 Chorley New Road, Bolton, BL1 4BY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Revenue is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

 

1.3
Non-current investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

PMRX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2019
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

PMRX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2019
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2019
2018
Number
Number
Total
2
2
3
Fixed asset investments
2019
2018
£
£
Investments
639,562
639,562
Movements in non-current investments
Investments other than loans
£
Cost or valuation
At 1 August 2018 & 31 July 2019
639,562
Carrying amount
At 31 July 2019
639,562
At 31 July 2018
639,562
4
Financial instruments
2019
2018
£
£
Carrying amount of financial assets
Instruments measured at fair value through profit or loss
639,562
639,562
5
Current liabilities
2019
2018
£
£
Bank loans
29,000
26,250
PMRX LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2019
- 5 -
6
Non-current liabilities
2019
2018
£
£
Bank loans
424,574
456,307
Other payables
100,000
100,000
524,574
556,307

The bank loans are secured by a cross guarantee with Fearns Pharmacy Ltd, which is an associated company.

Amounts included above which fall due after five years are as follows:
Payable by instalments
290,000
320,000
2019-07-312018-08-01false08 June 2020CCH SoftwareCCH Accounts Production 2020.100No description of principal activityMr J FearnsMr M J Fearns099056852018-08-012019-07-31099056852019-07-31099056852018-07-3109905685core:CurrentFinancialInstruments2019-07-3109905685core:CurrentFinancialInstruments2018-07-3109905685core:Non-currentFinancialInstruments2019-07-3109905685core:Non-currentFinancialInstruments2018-07-3109905685core:ShareCapital2019-07-3109905685core:ShareCapital2018-07-3109905685core:RetainedEarningsAccumulatedLosses2019-07-3109905685core:RetainedEarningsAccumulatedLosses2018-07-3109905685bus:Director12018-08-012019-07-31099056852017-08-012018-07-3109905685bus:PrivateLimitedCompanyLtd2018-08-012019-07-3109905685bus:SmallCompaniesRegimeForAccounts2018-08-012019-07-3109905685bus:FRS1022018-08-012019-07-3109905685bus:AuditExemptWithAccountantsReport2018-08-012019-07-3109905685bus:Director22018-08-012019-07-3109905685bus:FullAccounts2018-08-012019-07-31xbrli:purexbrli:sharesiso4217:GBP